(Q38389783)

English

Novel targeted therapies in diffuse large B-cell lymphoma

scientific article published on 19 January 2015

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

title

Novel targeted therapies in diffuse large B-cell lymphoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 September 2017

Neha Mehta-Shah

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

Anas Younes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

publication date

19 January 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

published in

Seminars in Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

volume

52

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

page(s)

126-137

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35000501

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2009-12-257261

Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/1535-7163.MCT-12-0021

Identifiers

DOI

10.1053/J.SEMINHEMATOL.2015.01.007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

PubMed publication ID

25805592

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25805592

retrieved

2 September 2017

(Q38389783)

Novel targeted therapies in diffuse large B-cell lymphoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)